01/23/2026 | Media Statement
Fresenius Medical Care is preparing for the major winter storm forecast to impact much of the Southern, Central, Mid-Atlantic, and Northeastern regions in the United States this weekend. Our top priority is ensuring that patients can continue to access high-quality, life‑su ## Article Body 01/23/2026 | Media Statement Fresenius Medical Care is preparing for the major winter storm forecast to impact much of the Southern, Central, Mid-Atlantic, and Northeastern regions in the United States this weekend. Our top priority is ensuring that patients can continue to access high-quality, life‑sustaining dialysis care safely as severe weather develops. We are proactively educating patients on emergency preparedness, including the importance of not missing scheduled treatments which could put their lives at risk. We have asked them to keep their treatment information easily accessible in case of an emergency and to refill prescriptions well ahead of the storm. Our teams are adjusting operating schedules where appropriate to limit travel during periods of hazardous ice and snow and help ensure patients can complete their prescribed treatments. We remain connected with local authorities and have backup generators ready in many locations should power outages occur. Home dialysis patients are receiving guidance to proactively check their supplies and tips for managing treatments safely throughout the storm. Patients who need assistance or have questions about their dialysis center or schedule can call the Fresenius Kidney Care 24‑hour Patient Emergency Line at 1‑800‑626‑1297. Fresenius Medical Care is committed to ensuring that every person in need of dialysis treatment can receive care, regardless of their usual provider. In the event of a medical emergency, patients should call 911. As this storm brings dangerous cold, ice, and heavy snowfall across multiple states, Fresenius Medical Care remains committed to doing everything possible to support continuity of care and patient and staff safety throughout the event. Media Contact: Fresenius Medical Care Media Relations T +1 800 723-2384 media(at)freseniusmedicalcare.com Back To top: ## Recent Company News - 2026-07-29 07:00 EST — [Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients](https://biopharmsignal.com/news/FMS/fresenius-medical-care-announces-beacon-us-generating-real-world-evidence-suppor-8547f5f8) — Source: Fresenius Medical Care Ventures - 2026-07-20 07:00 EST — [Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy](https://biopharmsignal.com/news/FMS/fresenius-medical-care-introduces-therapywise-analytics-for-kidney-replacement-t-6fa82f2a) — Source: Fresenius Medical Care Ventures - 2026-06-10 07:00 EST — [Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model](https://biopharmsignal.com/news/FMS/interwell-health-delivers-strong-quality-scores-and-shared-savings-in-cms-value--e2c55e86) — Source: Fresenius Medical Care Ventures - 2026-06-03 07:00 EST — [Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis](https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-kinexus-worldwide-a-unified-digital-platform-to-support-home-dialysis) — Source: Fresenius Medical Care Ventures - 2026-05-28 07:00 EST — [Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million](https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-first-tranche-of-its-share-buyback-program-of-up-to-eur-600-million) — Source: Fresenius Medical Care Ventures ## Related News - 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627) - 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922) - 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c) - 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec) - 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)